Supernus Pharmaceuticals (SUPN) EPS (Diluted) (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted EPS (Diluted) of -$1.01 for Q2 2026, compared with $0.40 a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) EPS (Diluted) (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EPS (Diluted) at Supernus Pharmaceuticals was -$1.89; for FY2025, it was -$0.68.
- In prior years, Supernus Pharmaceuticals' EPS (Diluted) was $1.32 in FY2024, $0.02 in FY2023 (-97.6%), $0.98 in FY2022 (+0.1%) and $0.98 in FY2021 (-58.4%).
- The Q2 2026 figure stands as the lowest quarterly EPS (Diluted) since Q1 2013.
- The strongest year-over-year quarter for EPS (Diluted) in the past five years was Q4 2022, with growth of 819.6%; the weakest was Q1 2024, with a decline of 99.2%.
- According to Business Quant data, EPS (Diluted) for the three prior quarters was -$0.04 (Q1 2026), -$0.07 (Q4 2025) and -$0.80 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 4.31 |
| 10 | Supernus Pharmaceuticals | 2.59 Bn | 1.25 Bn | 185.39 Mn | -1.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.01 |
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.07 |
| Sep 30, 2025 | -0.80 |
| Jun 30, 2025 | 0.40 |
| Mar 31, 2025 | -0.21 |
| Dec 31, 2024 | 0.27 |
| Sep 30, 2024 | 0.69 |
| Jun 30, 2024 | 0.36 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | -0.29 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | 0.27 |
| Dec 31, 2022 | 0.41 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.13 |
| Mar 31, 2022 | 0.42 |
| Dec 31, 2021 | 0.04 |
| Sep 30, 2021 | 0.40 |
API Access
Supernus Pharmaceuticals EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();